Non-Hodgkin Lymphoma | Tumor

CURE’s non-Hodgkin lymphoma (NHL) page is an extensive resource of cancer information featuring the latest NHL news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on non-Hodgkin lymphoma.

Drug Duo Granted Priority Review to Treat Waldenstrom Macroglobulinemia

June 25th 2018, 6:50pm

Article

The FDA has granted a priority review to a supplemental new drug application (sNDA) Imbruvica (ibrutinib) for use in combination with Rituxan (rituximab) as a treatment option across all lines of therapy for patients with Waldenström macroglobulinemia.

Lymphoma Subgroup Experiences Durable Responses from Kymriah Treatment

June 20th 2018, 9:16pm

Article

Treatment with chimeric antigen receptor (CAR)-T cell therapy showed encouraging rates of durable responses among adult patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), according to updated data from the pivotal JULIET trial.

Great Expectations

June 19th 2018, 5:22pm

Article

Why the proverb, "you should never judge a man until you've walked a mile in his shoes" is true for both cancer patients and survivors.

First Roundup Case Goes to Court, But the Jury Is Still Out on Whether it Causes Cancer

June 19th 2018, 12:40am

Article

Dewayne Johnson is the first of hundreds of patients to take Monsanto to trial, claiming that Roundup caused them to get cancer. His case will be seen even sooner than others because in California dying plaintiffs can be given expedited trials.

A Song for Cancer Survivors

May 27th 2018, 12:23am

Article

This is what surviving cancer sounds like.

Navigating the Waves of Cancer Treatment

May 17th 2018, 4:53pm

Podcast

In this week’s episode of CURE Talks Cancer, we spoke with Matt Lashey, creator and CEO of the chemoWave app, which is designed to manage cancer symptoms and conditions by keeping track of a patient’s overall well-being to understand how their experiences may be related to feeling better or worse during treatment.

Genomic Analysis Points to More Effective Treatment Options in Lymphoma Subtype

May 15th 2018, 5:18pm

Article

Thanks to genomic analysis by scientists at the Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard, diffuse large B cell lymphoma (DLBCL) is now a little easier to understand – and possibly easier to treat.

Long, Long Ago, on an Island Far, Far Away

May 9th 2018, 5:42pm

Article

chemoWave Propels Patients to Take Back Control in Cancer Treatment

May 8th 2018, 12:46am

Article

The chemoWave app, launched in July 2017, is designed to manage cancer symptoms and conditions by keeping track of a patient’s overall well-being.

Study Demonstrates Potential for New CLL Combination

March 9th 2017, 2:00am

Article

A recent phase 3 study showed that Imbruvica plus ublituximab may be a promising option for some patients with CLL.